[ACRS] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
07-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -10.91%
YoY- -68.96%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 2,046 1,407 1,095 983 5,865 5,041 3,669 -32.27%
PBT -11,570 -15,328 -19,177 -23,138 -49,876 -37,565 -38,551 -55.20%
Tax 27 -318 -32,181 32,733 18,504 0 -958 -
NP -11,597 -15,586 -18,594 -55,319 -49,876 -37,565 -38,551 -55.13%
Tax Rate - - - - - - - -
Total Cost 13,643 16,993 19,689 56,302 55,741 42,606 42,220 -52.94%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -566.81 -1,107.75 -1,698.08 -5,627.57 -850.40 -745.19 -1,050.72 -33.75%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.28 -0.37 -0.45 -1.34 -1.21 -0.91 -0.99 -56.94%
EPS Diluted -0.28 -0.37 -0.45 -1.34 -1.21 -0.91 -0.99 -56.94%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.